SJM Stock Climbs As Analysts Tout Upside Into Earnings

The J.M. Smucker Company stocks have been trading up by 11.25 percent after strong earnings and upbeat forward guidance.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading SJM

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Analysts are leaning constructive on SJM even as packaged-food demand softens and inflation stays sticky across the sector.
UBS and RBC see The J.M. Smucker Company as a relative standout, with medium‑term organic growth and solid bottom-line potential.
Morgan Stanley calls SJM the best-screening name in its coverage, despite trimming 2027 EPS and staying Equal Weight.
Street targets around $116–$116.50 imply double‑digit upside from recent SJM trading near $100–$102.
Upcoming earnings, with a $2.64 EPS bar, and FY27 commentary are the next key catalysts for SJM traders.

Live Update At 12:33:13 EDT: On Tuesday, June 09, 2026 The J.M. Smucker Company stock [NYSE: SJM] is trending up by 11.25%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

SJM has quietly put together a solid-looking base on the chart. Over the past few weeks, The J.M. Smucker Company has mostly traded between $100 and $105, then ripped to a $113.24 close on 2026/06/09 after touching an intraday high above $115. That move followed a prior close of $101.77, a sharp one-day surge that tells traders money is rotating back into the name ahead of earnings.

Intraday action shows steady buying pressure. On the latest session, SJM opened at $106.96 and pushed quickly through $110, with only shallow pullbacks on each five‑minute candle. That kind of trend, with higher highs and higher lows through midday, is exactly what momentum traders like to see when a catalyst is close.

More Breaking News

Fundamentally, SJM is more complex. Reported margins are distorted by a large impairment charge, which pushed recent net income to a loss of about $724.2M. But cash flow tells a different story: operating cash flow near $558.5M and free cash flow around $487M show the core business is still generating real cash. Leverage is high—total debt to equity about 1.42 and interest coverage only 0.4—so SJM is not a “no‑risk” balance sheet. Still, a roughly 4.3% dividend yield signals that management is confident enough in cash generation to keep paying out while it works through restructuring.

Why Traders Are Watching SJM Into Earnings

This week, SJM is back on traders’ radar for a simple reason: the Street is lining up behind the story into earnings. Wall Street is looking for $2.64 in EPS when The J.M. Smucker Company reports off‑cycle, and several big firms have refreshed their views right into that print.

UBS cut its SJM price target to $121 from $132, but the tone stayed bullish. The firm reiterated a Buy and went out of its way to highlight SJM as a partial exception in a beaten‑up packaged-food group. UBS still sees a credible path to organic sales growth and strong bottom‑line improvement over the next 12–18 months. For traders, that matters more than the headline target cut—$121 is still well above recent trading around $100–$113.

RBC Capital lands in a similar spot. It expects SJM’s fiscal Q4 results and 2027 guidance to land roughly in line with expectations, flagging coffee strength balanced against softer pet and mixed frozen handhelds and spreads. RBC keeps an Outperform rating and a $130 target, implying sizable upside from the low‑$100s. The recent 2.7% pop in SJM came after those comments, a sign that the market is starting to price in that more optimistic outlook.

Morgan Stanley is more reserved but still quietly supportive. It nudged its SJM target up to $106 from $104, trimmed 2027 EPS a bit, and stuck with an Equal Weight rating. Yet it also called SJM the best-screening name in its group, with the least earnings-revision risk under ongoing inflation and Iran‑related input cost pressure. Add in an overall Overweight consensus and a mean target around $116–$116.50, and traders are staring at a setup where most analysts see double‑digit upside from here.

Conclusion

For active traders, SJM sits at an interesting intersection of chart momentum and steady, if cautious, Wall Street support. The J.M. Smucker Company just broke out from a month‑long base near $100, powering into the low‑$110s with strong intraday volume and clean five‑minute trend structure. At the same time, UBS, RBC, and Morgan Stanley are all telling clients the same basic story: the packaged‑food sector is challenged, but SJM looks like one of the better houses on a rough street.

The near‑term catalyst is clear. Earnings with a $2.64 EPS bar, plus updated FY27 commentary, will either confirm the bullish thesis or knock SJM back into its prior range. Coffee strength versus softer pet and frozen products will be key tells. If SJM shows that cash flow stays strong and leverage is manageable, the Street’s $116–$130 target band remains in play. If not, those targets get revisited.

Either way, traders should treat SJM like any catalyst name—plan entries, define risk, and do not fall in love with the story. As Tim Sykes likes to remind his students, “The market doesn’t owe you anything; it only rewards preparation and discipline.” That’s closely aligned with the mindset echoed by many short‑term trading educators; as Tim Bohen, lead trainer with StocksToTrade says, “Preparation is half the trade. By the time the bell rings, my decisions are nearly made.”. For SJM, that means mapping the key levels, knowing the earnings expectations cold, and being ready to cut losses fast if the trade turns against you. This analysis is for educational and research purposes only, and every trader must make their own decisions in the market.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!